TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00847171 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03959228 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 19
Genes: FGF19; UNQ334/PRO533
Study NCT04269278 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT01488565 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01552122 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01461330 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02107677 — Predictive Biomarker (PRD): IVNS1ABP mRNA
Genes: IVNS1ABP; ARA3; FLARA3; KIAA0850; KLHL39; NS1; NS1BP; HSPC068
Study NCT00415571 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT05172895 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03480217 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03341403 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT02004314 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02004314 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT04406116 — Predictive Biomarker (PRD): HCLS1 mRNA
Genes: HCLS1; HS1
Study NCT02788669 — Predictive Biomarker (PRD): LRP1 mRNA
Genes: LRP1; A2MR; APR
Study NCT02788669 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT02799888 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT01943097 — Predictive Biomarker (PRD): DDC mRNA
Genes: DDC; AADC
Study NCT03203278 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00814879 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study NCT01343225 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01343225 — Predictive Biomarker (PRD): CYP24A1 mRNA
Genes: CYP24A1; CYP24
Study NCT01462162 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01359540 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03906227 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study NCT03906227 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT04403100 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02934828 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02934828 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00621972 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00621972 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02343887 — Predictive Biomarker (PRD): CPE mRNA
Genes: CPE
Study NCT01689506 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT03778229 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT03778229 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03252184 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02903511 — Surrogate Endpoint (SUR): Total kidney volume
Study NCT05458726 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03401853 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00385086 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00072969 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01419535 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00813228 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00813228 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study NCT03173495 — Predictive Biomarker (PRD): PPL mRNA
Genes: PPL; KIAA0568
Study NCT03173495 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02278471 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04071119 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01300117 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study NCT01604681 — Safety Biomarker (SAF): MTHFR
Study NCT01810744 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02569489 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02374632 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT03319290 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT02438072 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT02438072 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT02438072 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT02438072 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT02438072 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03932136 — Predictive Biomarker (PRD): 14-3-3 protein sigma
Genes: SFN; HME1
Study NCT03811600 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02903576 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT00315068 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00674167 — Predictive Biomarker (PRD): RUNX3 mRNA
Genes: RUNX3; AML2; CBFA3; PEBP2A3
Study NCT04476823 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00785122 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00035815 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04430530 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT04430530 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT03465657 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03346863 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study NCT00974779 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04587180 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01214512 — Predictive Biomarker (PRD): CD24 mRNA
Genes: CD24; CD24A
Study NCT00599781 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT03127748 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT01070797 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01737164 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT04589494 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03333954 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00923091 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02492711 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03921372 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01857310 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT01860846 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00949650 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00949650 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00199186 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00199186 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT01686503 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05417529 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02758366 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT00999752 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04722133 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03414918 — Predictive Biomarker (PRD): KCNJ5 mRNA
Genes: KCNJ5; GIRK4
Study NCT03414918 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01988038 — Predictive Biomarker (PRD): PRKD1 mRNA
Genes: PRKD1; PKD; PKD1; PRKCM
Study NCT01172171 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00379938 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02521350 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02832583 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02770261 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01757457 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04791891 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT00926068 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT01751646 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00945191 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT02187029 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT00077233 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02495233 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03951428 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT03300453 — Predictive Biomarker (PRD): NAGLU mRNA
Genes: NAGLU; UFHSD1
Study NCT04642183 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02519764 — Surrogate Endpoint (SUR): Serum sodium
Study NCT01066663 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT02079441 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04361097 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02710500 — Predictive Biomarker (PRD): DYSF mRNA
Genes: DYSF; FER1L1
Study NCT03927599 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT04627519 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00274326 — Surrogate Endpoint (SUR): Serum sodium
Study NCT04539587 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00471471 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00210262 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00210262 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02360748 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT02360748 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT00823342 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02503345 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT00989586 — Predictive Biomarker (PRD): CD74 mRNA
Genes: CD74; DHLAG
Study NCT00450463 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04715750 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT02194881 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02845518 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02845518 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT00757107 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03726463 — Predictive Biomarker (PRD): PRKD1 mRNA
Genes: PRKD1; PKD; PKD1; PRKCM
Study NCT03726463 — Predictive Biomarker (PRD): PKD2 mRNA
Genes: PKD2; TRPP2
Study NCT04020575 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT00171782 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02400203 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01318746 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT02130700 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CYP17A1 mRNA
Genes: CYP17A1; CYP17; S17AH
Study NCT02130700 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT03645226 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT01749072 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01749072 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02192775 — Predictive Biomarker (PRD): SLC5A5 mRNA
Genes: SLC5A5; NIS
Study NCT02186132 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03676985 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03515785 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT03515785 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT02089828 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05167292 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02854683 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02685605 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT03631329 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04002323 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03825042 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00379483 — Predictive Biomarker (PRD): Liver iron
Study NCT01871064 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT03918668 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT03918668 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT03918668 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT04449471 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT02124109 — Predictive Biomarker (PRD): RHD mRNA
Genes: RHD
Study NCT01415960 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT00711503 — Safety Biomarker (SAF): Interleukin 1
Study NCT00154037 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01767441 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT04083196 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01449058 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT01449058 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01449058 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT00867477 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT04124718 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT02006147 — Predictive Biomarker (PRD): DSP mRNA
Genes: DSP
Study NCT05696860 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00671047 — Predictive Biomarker (PRD): SAGE1 mRNA
Genes: SAGE1; SAGE
Study NCT04500678 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04500678 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT04500678 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT04500678 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04317196 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT03210285 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study NCT01461473 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03841838 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03402048 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study NCT03402048 — Predictive Biomarker (PRD): Ribonucleoside-diphosphate reductase large subunit
Genes: RRM1; RR1
Study NCT03402048 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT04103268 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02513940 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT00504582 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03043365 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02815033 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT00095121 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00057005 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study NCT00119483 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT00367406 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03446547 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00146549 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02958410 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT01646684 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT00449059 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03903055 — Predictive Biomarker (PRD): PAFAH1B1 mRNA
Genes: PAFAH1B1; LIS1; MDCR; MDS; PAFAHA
Study NCT03903055 — Predictive Biomarker (PRD): FUT1 mRNA
Genes: FUT1; H; HSC
Study NCT03903055 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02504892 — Predictive Biomarker (PRD): FLCN mRNA
Genes: FLCN; BHD
Study NCT01233752 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT01276847 — Safety Biomarker (SAF): Interleukin 12
Study NCT01276847 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00306202 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study NCT00306202 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT03414164 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT02693899 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT02970851 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01612728 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03206073 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03206073 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03206073 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03206073 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00400946 — Surrogate Endpoint (SUR): Serum asparaginase
Study NCT04325373 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04325373 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01404897 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01954628 — Predictive Biomarker (PRD): INPP5D mRNA
Genes: INPP5D; SHIP; SHIP1
Study NCT01823653 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study NCT03593434 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT00968357 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT04599816 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05541068 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT00004832 — Predictive Biomarker (PRD): DAP mRNA
Genes: DAP; DAP1
Study NCT03093545 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00447954 — Predictive Biomarker (PRD): CNTF mRNA
Genes: CNTF
Study NCT03076567 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study NCT01611077 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03078101 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03078101 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT03078101 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03078101 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03470974 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02584569 — Predictive Biomarker (PRD): PDE2A mRNA
Genes: PDE2A
Study NCT02047123 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02723578 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02723578 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT02723578 — Safety Biomarker (SAF): DHFR
Genes: DHFR1
Study NCT01335477 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01355991 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT01094639 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01094639 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03758677 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01181505 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT02558426 — Predictive Biomarker (PRD): GPER1 mRNA
Genes: GPER1; CEPR; CMKRL2; DRY12; GPER; GPR30
Study NCT02558426 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02034305 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT02202811 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00510692 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT00510692 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT01312610 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02808572 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT04643171 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04643171 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT05963061 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT05963061 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT02591784 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02591784 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03437759 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02069418 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02069418 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01084252 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT03187327 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01736410 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT01736410 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL